AGT Polyclonal Antibody

Background:
The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.

Research Area: Cancer, Cardiovascular, Metabolism, Signal Transduction

Synonyms:
Aangiotensinogen (serpin peptidase inhibitor clade A member 8), AGT, AI265500, Alpha 1 antiproteinase antitrypsin, Ang, Ang I, Ang II, Ang III, AngII, Angiotensin I, Angiotensin II, Angiotensin III, Angiotensin-3, Angiotensinogen (PAT), Angiotensinogen, ANGT, ANHU, ANRT, AT-2, AT-II, Des-Asp[1]-angiotensin II, FLJ92595, FLJ97926, MGC105326, PAT, Pre angiotensinogen, Serine (or cysteine) proteinase inhibitor, Serpin A8, Serpin peptidase inhibitor clade A member 8, SERPINA8

Immunogen: Synthetic peptide of human AGT

Swissprot: P01019
Gene Accession: NP_000020

Calculated MW: 53 kDa

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.2 mg/mL
Dilution: WB 1:500-1:2000, IHC 1:25-1:100

Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Alternative for product with catalog number:
sc-7419/sc-20717